Spots Global Cancer Trial Database for Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)

Official Title: Observational Study to Assess Real-World Outcomes in Patients With Unresectable Liver Tumors Initiating Treatment With SIR-Spheres (Y-90 Resin Microspheres) (SIRtain Registry)

Study ID: NCT05967143

Conditions

Unresectable Hepatocellular Carcinoma (HCC)

Liver Metastases From Colorectal Cancer (mCRC)

Interventions

SIRT

Study Description

Brief Summary: This registry seeks to prospectively gather a large repository of comprehensive observational data reflecting routine use of SIR-Spheres in patients diagnosed with unresectable HCC or unresectable liver metastases from mCRC refractory to or intolerant to chemotherapy, in order to assess clinical response in a real-world setting and further validate the safe and appropriate use of SIR-Spheres

Detailed Description: This is a global, multi-center, prospective, observational cohort study (registry) to assess real-world outcomes in patients with unresectable HCC or unresectable liver metastases from mCRC refractory to or intolerant to chemotherapy who have been prescribed SIRT with SIR-Spheres per medical decision. The study will be conducted through the involvement of approximately 845 patients from up to 44 sites in an estimated 10 countries.